Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph F Hayes

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
BMC Medicine|March 7, 2025
Psychiatric and neuropsychiatric sequelae of COVID-19 within 2 years: a multinational cohort studyYi Chai, Ivan C H Lam, Kenneth K C Man, et al.
The Lancet Regional Health. Western Pacific|October 28, 2025
Psychotropic medication consumption before and after onset of COVID-19 pandemic in 91 countries and regions: a time-series analysisCaige Huang, Yu Yang, Yue Wei, et al.
The Lancet Regional Health. Western Pacific|May 31, 2022
Mortality-causing mechanisms and healthcare resource utilisation of treatment-resistant depression: A six-year population-based cohort studyVivien Ky Chan, Edmund Cl Cheung, Sandra Sm Chan, et al.
Nature Communications|August 17, 2023
Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend studyAdrienne Y L Chan, Andrew S C Yuen, Daniel H T Tsai, et al.
JAMA Psychiatry|July 9, 2025
Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-AnalysisMichail Kalfas, Dimosthenis Tsapekos, Matthew Butler, et al.
The Lancet. Psychiatry|October 3, 2025
Disease relapse, all-cause mortality, and adverse events associated with long-acting injectable antipsychotics versus oral antipsychotics in older people with schizophrenia in Hong Kong: a population-based within-subject analysisYue Wei, Vincent K C Yan, David J Castle, et al.
The Lancet. Digital Health|February 22, 2021
Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based studyKathryn E Mansfield, Rohini Mathur, John Tazare, et al.
Eclinicalmedicine|July 12, 2023
Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platformRuth E Costello, John Tazare, Dominik Piehlmaier, et al.
Epidemiology and Psychiatric Sciences|March 3, 2024
Incidence of mental health diagnoses during the COVID-19 pandemic: a multinational network studyYi Chai, Kenneth K C Man, Hao Luo, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 1, 2019
Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: consensus definition - CORRIGENDUMDiego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
BMC Medicine|March 7, 2025
Psychiatric and neuropsychiatric sequelae of COVID-19 within 2 years: a multinational cohort studyYi Chai, Ivan C H Lam, Kenneth K C Man, et al.
The Lancet Regional Health. Western Pacific|October 28, 2025
Psychotropic medication consumption before and after onset of COVID-19 pandemic in 91 countries and regions: a time-series analysisCaige Huang, Yu Yang, Yue Wei, et al.
The Lancet Regional Health. Western Pacific|May 31, 2022
Mortality-causing mechanisms and healthcare resource utilisation of treatment-resistant depression: A six-year population-based cohort studyVivien Ky Chan, Edmund Cl Cheung, Sandra Sm Chan, et al.
Nature Communications|August 17, 2023
Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend studyAdrienne Y L Chan, Andrew S C Yuen, Daniel H T Tsai, et al.
JAMA Psychiatry|July 9, 2025
Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-AnalysisMichail Kalfas, Dimosthenis Tsapekos, Matthew Butler, et al.
The Lancet. Psychiatry|October 3, 2025
Disease relapse, all-cause mortality, and adverse events associated with long-acting injectable antipsychotics versus oral antipsychotics in older people with schizophrenia in Hong Kong: a population-based within-subject analysisYue Wei, Vincent K C Yan, David J Castle, et al.
The Lancet. Digital Health|February 22, 2021
Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based studyKathryn E Mansfield, Rohini Mathur, John Tazare, et al.
Eclinicalmedicine|July 12, 2023
Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platformRuth E Costello, John Tazare, Dominik Piehlmaier, et al.
Epidemiology and Psychiatric Sciences|March 3, 2024
Incidence of mental health diagnoses during the COVID-19 pandemic: a multinational network studyYi Chai, Kenneth K C Man, Hao Luo, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 1, 2019
Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: consensus definition - CORRIGENDUMDiego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
Pageof 11